Hydrochlorothiazide/nebivolol hydrochlorideAlternative Names: Conébilox; HCTZ/nebivolol; Hydrochlorothiazide/nebivolol; Hypoloc-plus; Hyporetic; Lobidiur; Nebilet Comp; Nebilet Plus; Nebilet Plus H; Nebivolol hydrochloride/hydrochlorothiazide; Nebivolol plus HCTZ; Nebivolol/HCTZ; Nebivolol/hydrochlorothiazide; Nebizide; Nomexor plus HCT; Silostar Plus
Latest Information Update: 22 Feb 2017
At a glance
- Originator Menarini
- Class Antihypertensives; Benzopyrans; Benzothiadiazines; Ethanolamines; Fluorobenzenes; Heart failure therapies; Small molecules
- Mechanism of Action Beta 1 adrenergic receptor antagonists; Thiazide diuretics
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypertension
Most Recent Events
- 22 Feb 2017 Chemical structure information added